Laura Alfaro-HernándezDalia Ramírez-RamírezRubí Romo‐RodríguezKaren Ayala-ContrerasÁngeles Del Campo-MartínezEnrique López‐AguilarJanet Flores LujanoAldo Allende-LópezErika Alarcón-RuizMa. del Rocío Baños-Lara2026-03-222026-03-22202510.3389/fonc.2025.1614445https://doi.org/10.3389/fonc.2025.1614445https://andeanlibrary.org/handle/123456789/44056Citaciones: 3Centralized, standardized MRD monitoring at the CCCL was associated with a reduction in early mortality and improved one-year survival in children with B-ALL from a socioeconomically vulnerable population. These findings demonstrate the clinical value and feasibility of implementing MRD-informed response assessment in LMICs and highlight the potential of centralized diagnostic platforms to reduce survival disparities in childhood leukemia.enMedicineImmunophenotypingHazard ratioMinimal residual diseaseConfidence intervalInternal medicinePediatricsImpact of standardized immunophenotyping and MRD monitoring on early mortality reduction in childhood leukemia: a step towards addressing healthcare disparities in vulnerable populations from Southern Mexicoarticle